Cognition Therapeutics Inc (CGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,502 | -4,570 | -23,487 | -20,144 | -15,214 |
| Depreciation Amortization | 123 | 68 | 228 | 167 | 106 |
| Accounts receivable | 6,972 | 6,266 | -7,237 | 786 | -3,599 |
| Accounts payable and accrued liabilities | N/A | -7,570 | 3,510 | -4,904 | N/A |
| Other Working Capital | -849 | -1,375 | -3,457 | -2,903 | -1,599 |
| Other Operating Activity | -6,339 | 1,639 | 5,855 | 5,847 | 4,806 |
| Operating Cash Flow | $-8,595 | $-5,542 | $-24,588 | $-21,151 | $-15,500 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20 | N/A | 9 | N/A | N/A |
| Investing Cash Flow | $-20 | $N/A | $9 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,781 | 44 | 37,087 | 36,331 | 2,337 |
| Other Financing Activity | -404 | -277 | -517 | -366 | -289 |
| Financing Cash Flow | $6,377 | $-233 | $36,570 | $35,965 | $2,048 |
| Beginning Cash Position | 37,000 | 37,000 | 25,009 | 25,009 | 25,009 |
| End Cash Position | 34,762 | 31,225 | 37,000 | 39,823 | 11,557 |
| Net Cash Flow | $-2,238 | $-5,775 | $11,991 | $14,814 | $-13,452 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,595 | -5,542 | -24,588 | -21,151 | -15,500 |
| Capital Expenditure | -20 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -8,615 | -5,542 | -24,588 | -21,151 | -15,500 |